Results 31 to 40 of about 99,805 (324)

Medication Risk and Polypharmacy in Minority Older Adults [PDF]

open access: yes, 2020
Medication Risk and Polypharmacy in Minority Older Adults Rusha Patel, Depts. of Biology and Chemistry, with Dr. Youssef Roman, VCU School of Pharmacy, Dr. Elvin Price, VCU School of Pharmacy, and Dr.
Patel, Rusha
core   +1 more source

The potential for deprescribing in care home residents with Type 2 diabetes [PDF]

open access: yes, 2016
Background: Type 2 diabetes is a common diagnosis in care home residents that is associated with potentially inappropriate prescribing and thus risk of additional suffering.
Andreassen, Lillan Mo   +4 more
core   +1 more source

Is shared decision-making a determinant of polypharmacy in older patients with chronic disease? A cross-sectional study in Hubei Province, China

open access: yesBMC Geriatrics, 2023
Background Shared decision-making(SDM) is recognized as an important means of managing polypharmacy among older people with chronic diseases. However, no studies have quantitatively measured the effect of SDM on polypharmacy.
Qiao Zong   +5 more
doaj   +1 more source

Potentially inappropriate prescribing in nursing home residents detected with the community pharmacist specific GheOP3S-tool [PDF]

open access: yes, 2016
Background: The Ghent Older People’s Prescriptions community Pharmacy Screening (GheOP3S-)tool was recently developed to screen for potentially inappropriate prescribing (PIP).
Boussery, Koen   +7 more
core   +1 more source

Regional differences in the profile of disabled community-dwelling older adults: a European population-based cross-sectional study [PDF]

open access: yes, 2018
The main objective of this work was to estimate the prevalence of disability in European community-dwelling older adults, as well as to investigate differences in the profile of disabled older adults between European regions (Northern, Central, Eastern ...
Bagur-Calafat , Caritat   +6 more
core   +6 more sources

Polypharmacy, socioeconomic indicators and number of diseases: results from ELSA-Brasil [PDF]

open access: yesRevista Brasileira de Epidemiologia, 2020
: Objective: To estimate the prevalence of polypharmacy, describe the pharmacotherapeutic classes used, and investigate whether polypharmacy is associated with demographic and socioeconomic indicators, regardless of the number of diseases, among ...
Isabella Ribeiro Silva   +8 more
doaj   +1 more source

Issues potentially affecting quality of life arising from long-term medicines use: a qualitative study [PDF]

open access: yes, 2013
Background Polypharmacy is increasing and managing large number of medicines may create a burden for patients. Many patients have negative views of medicines and their use can adversely affect quality of life.
A Alic   +40 more
core   +1 more source

Rational polypharmacy

open access: yesSeizure, 1995
The development of assays for plasma antiepileptic drug concentrations has led to the discovery of many pharmacokinetic interactions, some causing drug intoxication and others resulting in ineffective drug concentrations. In the 1970s, a number of epileptologists began to argue that single drug therapy was desirable in the treatment of epilepsy and ...
openaire   +4 more sources

Do frailty and comorbidity indices improve risk prediction of 28-day ED reattendance? Reanalysis of an ED discharge nomogram for older people [PDF]

open access: yes, 2018
Background: In older people, quantification of risk of reattendance after emergency department (ED) discharge is important to provide adequate post ED discharge care in the community to appropriately targeted patients at risk. Methods: We reanalysed data
A Elixhauser   +15 more
core   +2 more sources

Polypharmacy in African American Adults: A National Epidemiological Study

open access: yesPharmacy, 2019
Background: Despite the association between polypharmacy and undesired health outcomes being well established, very little is known about epidemiology of polypharmacy in the African American community.
Shervin Assari   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy